Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Fish and Richardson
Harvard Business School

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060704

« Back to Dashboard

NDA 060704 describes TETRACYCLINE HYDROCHLORIDE, which is a drug marketed by Abbott, Chartwell Tetra, Elkins Sinn, Ferrante, Heather, Hikma Pharms, Idt Australia Ltd, Impax Labs, Ivax Sub Teva Pharms, Mast Mm, Mylan, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Valeant Pharm Intl, Warner Chilcott, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, and Proter, and is included in twenty-six NDAs. It is available from thirteen suppliers. Additional details are available on the TETRACYCLINE HYDROCHLORIDE profile page.

The generic ingredient in TETRACYCLINE HYDROCHLORIDE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Summary for 060704

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 060704


Suppliers and Packaging for NDA: 060704

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060704 ANDA Liberty Pharmaceuticals, Inc. 0440-8505 0440-8505-91 120 CAPSULE in 1 BOTTLE (0440-8505-91)
TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060704 ANDA Blenheim Pharmacal, Inc. 10544-590 10544-590-30 30 CAPSULE in 1 BOTTLE (10544-590-30)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance
Federal Trade Commission
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: